Detection of collagen triple helix repeat containing-1 and nuclear factor (erythroid-derived 2)-like 3 in colorectal cancer

BMC Clinical Pathology

Volumn 12, Issue , 2012, Pages

  Palma, Marco ^a   Lopez, Lissett ^a   García, Margarita ^a   De Roja, Nuria ^a   Ruiz, Tamara ^a   García, Julita ^a   Rosell, Elisabet ^b   Vela, Carmen ^a   Rueda, Paloma ^a   Rodriguez, María Jose ^a  

^a Inmunologia y Genetica Aplicada SA   (Spain)

^b ORYZON GENOMICS   (Spain)

Author keywords

Biomarker; Cancer; Cancer biomarker; Colorectal cancer; CRC; CTHRC1; DAS ELISA; DELFIA assay; Double antibody sandwich enzyme linked immunosorbent assay; NFE2L3; Nuclear factor (erythroid derived 2) like 3; Triple Helix Repeat Containing 1

Indexed keywords

COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1 PROTEIN; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; NUCLEAR FACTOR ERYTHROID DERIVED 2 LIKE 3 PROTEIN; POLYCLONAL ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; COLON ADENOCARCINOMA; COLORIMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; LYMPHOCYTE; WESTERN BLOTTING;

EID: 84863414137     PISSN: None     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-12-2     Document Type: Article

References (38)

1. Cancer statistics, 2003. Jemal A, et al. CA Cancer J Clin 2003 53 1 5 26 10.3322/canjclin.53.1.5 12568441 (Pubitemid 36163619)
2. Cancer statistics, 2008. Jemal A, et al. CA Cancer J Clin 2008 58 2 71 96 10.3322/CA.2007.0010 18287387 (Pubitemid 351521864)
3. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. Leonard GD, Brenner B, Kemeny NE, J Clin Oncol 2005 23 9 2038 2048 10.1200/JCO.2005.00.349 15774795 (Pubitemid 46211384)
4. Biomarker update for breast, colorectal and non-small cell lung cancer. Ross JS, Drug News Perspect 2010 23 1 82 10.1358/dnp.2010.23.1.1437316 20155222
5. Biomarkers predicting clinical outcome of epidermal growth factor receptor targeted therapy in metastatic colorectal cancer. Siena S, et al. J Nat Cancer Inst 2009 101 19 1308 1324 10.1093/jnci/djp280 19738166
6. Genetic prognostic and predictive markers in colorectal cancer. Walther A, et al. Nature Reviews Cancer 2009 9 7 489 499 10.1038/nrc2645 19536109
7. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Hammarström S, Seminars in Cancer Biol 1999 9 2 67 81 10.1006/scbi.1998.0119 (Pubitemid 29265523)
8. Biomarkers for colorectal cancer. Tanaka T, et al. Int J Mol Sci 2010 11 9 3209 3225 10.3390/ijms11093209 20957089
9. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. Paik S, et al. N Engl J Med 2004 351 27 2817 2826 10.1056/NEJMoa041588 15591335 (Pubitemid 40051905)
10. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. Paik S, et al. J Clin Oncol 2006 24 23 3726 3734 10.1200/JCO.2005.04.7985 16720680 (Pubitemid 46622311)
11. Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX(R) Colon Cancer Assay. Clark-Langone K, et al. BMC Cancer 2010 10 1 691 10.1186/1471-2407-10-691 21176237
12. Clinicopathologic correlation of up-regulated genes identified using cdna microarray and real-time reverse transcription-PCR in human colorectal cancer. Chiu S-T, et al. Cancer Epidemiol Biomarkers Prev 2005 14 2 437 443 10.1158/1055-9965.EPI-04-0396 15734970 (Pubitemid 40270109)
13. Expression analysis of the novel gene collagen triple helix repeat containing-1 (Cthrc1). Durmus T, et al. Gene Expression Patterns 2006 6 8 935 940 10.1016/j.modgep.2006.03.008 16678498 (Pubitemid 44309445)
14. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. Turashvili G, et al. BMC Cancer 2007 7 55 1 20 17199887
15. Collagen triple helix repeat containing 1 promotes melanoma cell adhesion and survival. Ip W, et al. J Cutan Med Surg 2011 15 2 103 110 21477558
16. Molecular cloning and functional characterization of a New Cap'n'Collar family transcription factor Nrf3. Kobayashi A, et al. J Biol Chem 1999 274 10 6443 6452 10.1074/jbc.274.10.6443 10037736 (Pubitemid 29111059)
17. Nrf3 negatively regulates antioxidant-response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. Sankaranarayanan K, Jaiswal AK, J Biol Chem 2004 279 49 50810 50817 10.1074/jbc.M404984200 15385560 (Pubitemid 40017819)
18. Functional and placental expression analysis of the human NRF3 transcription factor. Chenais B, et al. Mol Endocrinol 2005 19 1 125 137 15388789 (Pubitemid 40065964)
19. Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium. Santin AD, 2005 United States Patent US2005004853
20. Compositions and methods for treating and diagnosing cancer. Clarke, et al. 2007 United States Patent US20070099209
21. Method for diagnosing testicular seminomas. Nakamura, et al. 2006 United States Patent US20060194199
22. Nfe2l3 (Nrf3) deficiency predisposes mice to T-cell lymphoblastic lymphoma. Chevillard G, Paquet M, Blank V, Blood 2011 117 6 2005 2008 10.1182/blood-2010-02-271460 21148084
23. Identification of Importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimens. Nguewa P, et al. BMC Mol Biol 2008 9 1 103 10.1186/1471-2199-9-103 19014639
24. Epitope mapping of the nucleocapsid protein of European and North American isolates of porcine reproductive and respiratory syndrome virus. Rodriguez M, et al. J Gen Virol 1997 78 9 2269 2278 9292014 (Pubitemid 27387040)
25. Differentiation between human coronaviruses NL63 and 229E using a novel double-antibody sandwich enzyme-linked immunosorbent assay based on specific monoclonal antibodies. Sastre P, et al. Clin Vaccine Immunol 2011 18 1 113 118 10.1128/CVI.00355-10 21084464
26. Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity. Hoet RM, et al. Nature Biotechnology 2005 23 3 344 348 10.1038/nbt1067 15723048 (Pubitemid 41094423)
27. Enzyme-labeled antibodies: preparation and application for the localization of antigens. Nakane PK, Pierce GB, J Histochem Cytochem 1966 14 12 929 931 10.1177/14.12.929 17121392
28. The use of the avidin-biotin complex as a tool in molecular biology. Bayer EA, Wilchek M, Methods Biochem Anal 1980 26 1 45 7392958
29. Markers for diagnosis of cancer and its use. Shin I, et al. 2010 European Patent EP2177628A2
30. Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers. Tang L, et al. Clin Cancer Res 2006 12 12 3716 3722 10.1158/1078-0432.CCR-06-0030 16778098 (Pubitemid 44000252)
31. Method for colorectal tumor diagnosis. Maes T, et al. 2008 European Patent EP2008/010665
32. Studies of human breast cancer metastasis using nude mice. Price JE, Zhang RD, Cancer and Metastasis Reviews Netherlands: Springer 1990 285 297
33. Three-dimensional in vitro tissue culture models of breast cancer-a review. Kim J, Stein R, O'Hare M, Breast Cancer Research and Treatment Netherlands: Springer 2004 281 291 (Pubitemid 38987263)
34. Pathway-specific differences between tumor cell lines and normal and tumor tissue cells. Ertel A, et al. Mol Cancer 2006 5 1 55 10.1186/1476-4598-5- 55 17081305 (Pubitemid 44742653)
35. Collagen triple helix repeat-containing protein 1 precursor-Homo sapiens. UniProtKB, http://www.uniprot.org/uniprot/Q96CG8
36. Nuclear factor erythroid 2-related factor 3-Homo sapiens. UniProtKB, http://www.uniprot.org/uniprot/Q9Y4A8
37. The Nrf3 Transcription Factor Is a Membrane-bound Glycoprotein Targeted to the Endoplasmic Reticulum through Its N-terminal Homology Box 1 Sequence. Zhang Y, et al. J Biol Chem 2009 284 5 3195 3210 19047052
38. An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum. Ahmed N, et al. Proteomics 2003 3 10 1980 1987 10.1002/pmic.200300465 14625860 (Pubitemid 37305892)